{
    "code": "02026050",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02026050",
    "time": "2023-08-10 23:42:36",
    "許可證字號": "衛署藥輸字第026050號",
    "註銷狀態": "已註銷",
    "註銷日期": "110\/07\/05",
    "註銷理由": "自請註銷",
    "製造許可登錄編號": "",
    "有效日期": "112\/06\/04",
    "發證\/登錄日期": "102\/06\/04",
    "許可證\/登錄種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA00202605001",
    "中文品名": "歐善利&quot;山德士&quot;5毫克\/毫升注射液",
    "英文品名": "Oxaliplatin Sandoz 5mg\/ml concentrate for solution for infusion",
    "適應症": "和5-fluorouracil (5-FU)及folinic acid (FA)併用，作為-第三期結腸癌(Duke' sC)原發腫瘤完全切除手術後的輔助療法。-治療轉移性結腸直腸癌。和Capecitabine併用可用於局部晚期及復發\/轉移性胃癌之治療。",
    "劑型": "270注射劑",
    "包裝": "100支以下盒裝 10毫升，20毫升，30毫升，40毫升Type I glass vial with chlorobutyl stoppers and flip-off caps",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "OXALIPLATIN",
    "限制項目": "02輸　入 1Q不得輸入 24監視期滿學名藥",
    "申請商名稱": "台灣諾華股份有限公司",
    "申請商地址": "台北市中山區民生東路三段2號8樓",
    "主製造廠": [
        {
            "製造廠名稱": "EBEWE PHARMA GES.M.B.H.NFG. KG",
            "製造廠廠址": "MONDSEESTRABE 11, A-4866 UNTERACH AM ATTERSEE, AUSTRIA",
            "製造廠公司地址": "",
            "製造廠國別": "AUSTRIA",
            "製程": ""
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1012001600",
            "成分名稱": "OXALIPLATIN",
            "含量描述": "",
            "含量": "5.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "歐善利山德士注射液-仿單-106-11-15.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02026050&Seq=002&Type=9"
        },
        {
            "title": "歐善利山德士注射液-200毫克-標籤-106-11-15.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02026050&Seq=015&Type=8"
        },
        {
            "title": "歐善利山德士注射液-200毫克-外盒-106-11-15.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02026050&Seq=014&Type=8"
        },
        {
            "title": "歐善利山德士注射液-150毫克-標籤-106-11-15.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02026050&Seq=013&Type=8"
        },
        {
            "title": "歐善利山德士注射液-150毫克-外盒-106-11-15.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02026050&Seq=012&Type=8"
        },
        {
            "title": "歐善利山德士注射液-100毫克-標籤-106-11-15.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02026050&Seq=011&Type=8"
        },
        {
            "title": "歐善利山德士注射液-100毫克-外盒-106-11-15.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02026050&Seq=010&Type=8"
        },
        {
            "title": "歐善利山德士注射液-50毫克-標籤-106-11-15.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02026050&Seq=009&Type=8"
        },
        {
            "title": "歐善利山德士注射液-50毫克-外盒-106-11-15.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02026050&Seq=008&Type=8"
        }
    ]
}